AI Image
Over 20,000 Bottles of Blood Pressure Medication Recalled Nationwide
Yahoo • • health
Key Points:
- The FDA has issued a Class III voluntary recall for telmisartan and amlodipine blood pressure medications due to a "superpotent drug" issue, where the telmisartan content exceeds specifications.
- The recall affects 30-count bottles from Mylan Pharmaceuticals Inc. in specific lot numbers (3228113, 3228114, 3228115, 3228120, and 3228121) with expiration dates of October 31, 2026, and November 30, 2026.
- Over 21,000 bottles have been recalled nationwide; while the medication is too potent, the FDA states it is not likely to cause adverse health consequences.
- Patients prescribed these medications should check their lot numbers and expiration dates, stop taking affected products immediately, and consult their healthcare provider.
- Refunds may be available at pharmacies, and consumers with questions can contact the FDA at 1-888-INFO-FDA.
